Press "Enter" to skip to content

What’s Tunisia growing MedTech to battle COVID19 with restricted resources?

Many hospitals in Tunisia are creating an assortment of new technologies to fight the book coronavirus, even facing several setbacks in resources and funding.

To create such technology, medical researchers from the nation received about 13% of public capital in 2019, according to the Journal of the Tunisian Republic.

Complex tools

Dr. Mustafa Hamdi, together with his students in the National Institute of Applied Sciences and Technology (INSAT), has developed an internet platform which can help detect COVID-19 from the lungs of patients.

The stage contrasts the X-rays of a patient using COVID-19, to that of someone who’s suspected of getting the virus.

Dr. Hamdi claims the algorithm employed has a 92 percent accuracy rate and is easily operated.

“It provides us a dent in moments, it is instantaneous,” says that the artificial intelligence scientist.

His job is just one of 15 other people accepted by the Tunisian authorities since April of the year.

The project was attained after two weeks of study, which started in March, with a budget of $3,000.

Omar Khouaga is a Ph.D. student at INSAT working on the job and states that his team’s job in Tunisia stands out from similar technology that exists worldwide.

“This stage is within Canada and China, also, but the distinction is our system is open access, it might be used by everybody,” he informed Euronews.

Additionally, he says that the platform can conserve hours typically needed to get results, it may run 1,000 tests each day, and save the government $265 each evaluation.

Scanning for answers
Dr. Taher Gargah, the director of health in the Ministry of Health at Tunisia, is part of the research battling COVID-19 from the Nation.

He considers that the discovery of the platform might be a game-changer.

“This program can save time, and provides us a diagnosis aside from the normal test kit,” states Dr. Gargah. “It might give us the chance to prepare ourselves to prevent patients from moving throughout the COVID-19 symptoms at the time.”

The study team is continuing to create the stage for applications beyond the pandemic in the Les Jasmin Private Clinic at Tunis.

“This facility is well equipped, together with all the scanner and IRM, hence we’re planning on further growing our research to find early detection of different diseases like cancer,” states the creation’s founder.

The program has been tested for possible use in detecting cancerous cells within the patients’ lungs.

The Global Cancer Observatory estimates that roughly 46 from 100,000 inhabitants in Tunisia will develop lung cancer between 2019 and 2024.

Almost 70 beds, initially for lung cancer sufferers, were awarded to people with COVID-19 in Hospital Abdel Rahmen Mami Ariana at Tunisia.

It’s estimated that this innovative program and many others may decrease the load on Tunisian hospitals when treating sufferers of this pandemic, and lung cancer, equally.